ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,823, issued on Jan. 20, was assigned to Applied Therapeutics Inc. (New York).
"Inhibitors of aldose reductase" was invented by Andrew Wasmuth (New York).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to novel compounds and pharmaceutical compositions thereof, and methods for promoting healthy aging of skin, the treatment of skin disorders, the treatment of cardiovascular disorders, the treatment of renal disorders, the treatment of angiogenesis disorders, such as cancer, treatment of tissue damage, such as non-cardiac tissue damage, the treatment of evolving myocardial infarction, the treatment of ischemic injury, and t...